Brugada, Crisanta .

HRN: 26-73-11  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/21/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
02/21/2025
02/28/2025
IV
4.5g
Q8H
SEPSIS
Waiting Final Action 
02/21/2025
AZITHROMYCIN 500MG TABLET (TAB)
02/21/2025
02/25/2025
PO
500MG
OD
Pneumonia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: